WISeKey’s Subsidiary, WISe.ART Launches a Marketing Campaign Aiming to Enlist Galleries, Museums, and Artists on its MarketPlace


WISeKey’s Subsidiary, WISe.ART Launches a Marketing Campaign Aiming to Enlist Galleries, Museums, and Artists on its MarketPlace

Calling All Artists: Dive into the Future of Art with WISe.ART!

Geneva – October 13, 2023 – WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) solutions operating as a holding company, today announced that is subsidiary WISe.ART is launching a marketing campaign aiming to enlist galleries, museums, and artists on its NFT MarketPlace. Interested parties can join the platform vis WISe.ART.

How it works

  • The platform offers all artists and curators/agents the ability to join and submit applications. Onboarding is free.
  • WISe.ART vetting committee to evaluate each submission and connect with each artist personally.
  • WISe.ART welcomes tokenisation of collectibles such as jewellery, design, real estate gems and precious metals.
  • Artists to collect 80% of the sales price when their creations are sold and minted.

Why choose WISe.ART

  • Dynamic Marketplace: Join a growing marketplace where arts and technology come alive, connecting everyone, from curators to enthusiasts.
  • Beyond Just Digital: Whether you’re a traditional artist or a digital visionary, your art deserves the best. WISe.ART ensures each digital asset is authenticated and uniquely linked to its physical counterpart.
  • Security & Authenticity: Peace of mind is priceless. WISe.ART platform guarantees proof of ownership, provenance, and clear contracts for future use and monetization.
  • Unique Tokenisation Capabilities: Stand out with our distinctive designs, white labelling, and options tailored for curators and multipliers.
  • Mint & Trade on Hedera: Experience seamless minting and trading within the WISeKey ecosystem, built atop the robust Hedera platform.
  • Anonymity with Integrity: WISe.ART respects your privacy, while allowing you to remain anonymous, our KYC processes ensure a transparent and untainted marketplace for all.
  • Effortless Access: With WISeID, dive into the world of art on both web and mobile platforms, fortified by strong authentication.

The future of art is here, and it’s technological, authentic, and global. Embrace the change and become a part of the art evolution with WISe.ART!

Turn your passion into opportunities. Join us now! See our artists at https://platform.wise.art/artists-index/

About WISeKey: WISeKey International Holding Ltd (“WISeKey”, SIX: WIHN; Nasdaq: WKEY) is a global leader in cybersecurity, digital identity, and IoT solutions platform. It operates as a Swiss-based holding company through several operational subsidiaries, each dedicated to specific aspects of its technology portfolio. The subsidiaries include (i) SEALSQ Corp (Nasdaq: LAES), which focuses on semiconductors, PKI, and post-quantum technology products, (ii) WISeKey SA which specializes in RoT and PKI solutions for secure authentication and identification in IoT, Blockchain, and AI, (iii) WISeSat AG which focuses on space technology for secure satellite communication, specifically for IoT applications, and (iv) WISe.ART Corp which focuses on trusted blockchain NFTs and operates the WISe.ART marketplace for secure NFT transactions.

About WISe.ART: WISe.ART platform leverages WISeKey’s strong cybersecurity expertise, digital identity technology, and the power of blockchain to offer a unique marketplace for NFTs, connecting artists, buyers, and collectors, while ensuring the provenance and authenticity of digital artworks.

Press and investor contacts:

WISeKey International Holding Ltd

Company Contact:  Carlos Moreira
Chairman & CEO
Tel: +41 22 594 3000
[email protected] 
WISeKey Investor Relations (US)

Contact:  Lena Cati
The Equity Group Inc.
Tel: +1 212 836-9611
[email protected]


Disclaimer: This communication expressly or implicitly contains certain forward-looking statements concerning WISeKey International Holding Ltd and its business. Such statements involve certain known and unknown risks, uncertainties, and other factors, which could cause the actual results, financial condition, performance, or achievements of WISeKey International Holding Ltd to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. WISeKey International Holding Ltd is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

This press release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, and it does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. Investors must rely on their own evaluation of WISeKey and its securities, including the merits and risks involved. Nothing contained herein is, or shall be relied on as, a promise or representation as to the future performance of WISeKey.


Statement by Cassava Sciences Regarding an Internal CUNY Report Leaked to the Press

  • CUNY’s report makes no findings of data manipulation.
  • The “

    egregious misconduct

    ” cited in the report relates to internal record-keeping failures at CUNY.
  • CUNY’s report finds that internal record-keeping failures “

    prevented us [CUNY] from making an objective assessment

    ” of research misconduct.
  • Leak of CUNY report preceded by massive increase in short selling.

AUSTIN, Texas, Oct. 12, 2023 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today issued the following statement regarding an internal report purportedly prepared by City University of New York (CUNY). This report was leaked to the press. The leak of the CUNY report was preceded by a 40% increase in short selling activity in the stock of Cassava Sciences.

Beginning August 2021, short sellers executed a brutal, widely publicized “short-and-distort” campaign against Cassava Sciences. The short-sellers alleged that Cassava Sciences and its academic researcher at CUNY had engaged in data manipulation and other forms of research misconduct. In response to these allegations, CUNY initiated an internal investigation in Fall 2021. In 2022, Cassava Sciences filed a lawsuit against certain individuals who participated in the short-and-distort campaign, identifying over 1,000 false and defamatory statements.

On October 12, 2023, Science reported that it had obtained a copy of CUNY’s report from “a person who requested anonymity because they are not authorized to share it.” The Science article quotes a person paid by a lawyer for certain short-sellers, but does not indicate what role, if any, short-sellers had in the leak. According to Science, CUNY completed its investigation in May 2023. The short interest in Cassava Sciences’ stock jumped 40%, to over 14 million shares, between June 30, 2023, and September 29, 2023, according to NASDAQ.

CUNY’s report makes no findings of data manipulation. Rather, the “egregious misconduct” cited in the report relates exclusively to internal record-keeping failures at CUNY. The report also finds that internal record-keeping failures “prevented us [CUNY] from making an objective assessment” of the allegations of research misconduct.

“We remain confident in the underlying science for simufilam, our lead drug candidate,” said Remi Barbier, President & CEO. “We intend to continue to translate our passion for science into a novel drug for people living with Alzheimer’s disease. Our Phase 3 clinical program continues.”

Cassava Sciences played no role in CUNY’s investigation. The university turned down all requests for information and offers of assistance from Cassava. Because CUNY did not interview any employee of Cassava Sciences, the university has no legitimate basis on which to make accusations against the Company or its employees.

CUNY has not responded to an inquiry Cassava Sciences made yesterday regarding the authenticity of the leaked report.

Importantly, Cassava Sciences does not rely exclusively on research at CUNY. The science underlying simufilam, Cassava Sciences’ lead drug candidate, is supported by the work of scientists at academic institutions that have no connection to CUNY, including:

  • In September 2023, Cassava Sciences announced the publication of new research that confirms the biological activity of simufilam. Researchers at the Cochin Institute (Paris, France) used a highly precise cell-based assay to show that simufilam interrupts amyloid binding to the α7 nicotinic acetylcholine receptor. Cassava Sciences believes this protein interaction underlies simufilam’s mechanism of action in Alzheimer’s disease. The research appears in a special issue of International Journal of Molecular Sciences, a peer-reviewed scientific publication, and is currently available on-line at: https://www.mdpi.com/1422-0067/24/18/13927
  • In May 2023, Cassava Sciences announced the publication of new data that highlights the biological activity of simufilam on Filamin A. Researchers at the University of Milan (Italy) showed a functional interaction between simufilam, filamin A (FLNA) and somatostatin receptors. Specifically, the researchers showed that simufilam treatment significantly reduced levels of phosphorylation at a site on FLNA in human pituitary tumor cells. The research was presented at the 25thEuropean Congress of Endocrinology and is currently available on-line at: https://www.endocrine-abstracts.org/ea/0090/ea0090oc7.5
  • In February 2020, Cassava Sciences announced that filamin A inhibition by simufilam reduced seizure activity in a mouse model of epilepsy. The data was generated by researchers at Yale University, was published in Science Translational Medicine and is currently available on-line at: https://pubmed.ncbi.nlm.nih.gov/32075941/

Other independent researchers have shown a role for filamin A in neurodegeneration.

About Cassava Sciences, Inc.

Cassava Sciences is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease. Our product candidates have not been approved by any regulatory authority, and their safety, efficacy or other desirable attributes have not been established in humans.

For more information, please visit: https://www.CassavaSciences.com

For More Information Contact:

Eric Schoen, Chief Financial Officer
(512) 501-2450
[email protected]

Cautionary Note Regarding Forward-Looking Statements:

This news release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, relating to: the continuation of our Phase 3 clinical program; results of research relating to simufilam and to the mechanism of action underlying simufilam;
the treatment of patients with Alzheimer’s disease dementia;
comments made by our employees regarding the purported CUNY report, our science or simufilam and the treatment of Alzheimer’s disease; the continued development of simufilam; and potential benefits, if any, of our product candidates. These statements may be identified by words such as “may,” “anticipate,” “believe,” “could,” “expect,” “look forward,” “would”, “forecast,” “intend,” “plan,” “possible,” “potential,” and other words, phrases, and terms of similar meaning.

Simufilam is our investigational product candidate. Its safety, efficacy or science has not reviewed or approved by any regulatory authority in any jurisdiction and its desirable clinical attributes, if any, have not been established in patients.

Drug development involves a high degree of risk, and only a small number of research and development programs result in regulatory approval and commercialization of a product.
Clinical results from our prior studies may not be indicative of results of future or larger scale clinical trials and do not ensure regulatory approval.
You should not place undue reliance on these statements or any scientific data we present or publish.

Such statements are based largely on our current expectations and projections about future events. Such statements speak only as of the date of this news release and are subject to a number of risks, uncertainties and assumptions, including, but not limited to, those risks relating to the ability to conduct or complete clinical studies on expected timelines, to demonstrate the specificity, safety, efficacy or potential health benefits of our product candidates, any unanticipated impacts of inflation on our business operations, and including those described in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, and future reports to be filed with the SEC. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from expectations in any forward-looking statement. In light of these risks, uncertainties and assumptions, the forward-looking statements and events discussed in this news release are inherently uncertain and may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Accordingly, you should not rely upon forward-looking statements as predictions of future events. Except as required by law, we disclaim any intention or responsibility for updating or revising any forward-looking statements contained in this news release. For further information regarding these and other risks related to our business, investors should consult our filings with the SEC, which are available on the SEC’s website at



Weave Announces Date of Third Quarter 2023 Financial Results and Conference Call

Weave Announces Date of Third Quarter 2023 Financial Results and Conference Call

LEHI, Utah–(BUSINESS WIRE)–Weave (NYSE: WEAV), a leading all-in-one customer experience software platform for small and medium-sized healthcare businesses, today announced it will release its financial results for the third quarter 2023 after U.S. markets close on Wednesday, November 1, 2023. Company management will host a conference call and webcast at 5 p.m. ET to discuss Weave’s financial results and provide a business update.

Individuals interested in listening to the conference call may do so by dialing (412) 902-1020 or toll free at (877) 502-7186. The live webcast and a webcast replay of the conference call can be accessed from the investor relations page of Weave’s website at investors.getweave.com.

About Weave

Weave is the premier all-in-one customer experience software platform for small and medium sized healthcare businesses. Weave transforms how practitioners attract, engage, and retain customers to grow their businesses. Weave brings payments, texting, scheduling, reminders, reviews, phones and more together into one easy-to-use, efficiency and revenue boosting platform. Weave has set the bar for Utah startup achievement & work culture. In the past year alone, Weave has been named a leader in Patient Engagement, Optometry, Dental Practice Management and Patient Relationship Management by G2. Learn more at getweave.com/newsroom/.

Investor Contact:

Mark McReynolds

Head of Investor Relations

[email protected]

Media Contact:

Natalie House

Senior Director of Content & Communications

[email protected]

KEYWORDS: United States North America Utah

INDUSTRY KEYWORDS: Health Practice Management Technology Health Technology Software



Rocket Lab Announces Date of Third Quarter 2023 Financial Results

Rocket Lab Announces Date of Third Quarter 2023 Financial Results

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced that it will release its financial results for the third quarter 2023 following the close of the U.S. markets on Wednesday, November 8, 2023. Rocket Lab will host a corresponding conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

A live webcast and replay of the conference call will be available on the Company’s Investor Relations website at www.rocketlabusa.com/investors.

+ About Rocket Lab

Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier, and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle, the Photon satellite platform, and the Company is developing the large Neutron launch vehicle for constellation deployment. Since its first orbital launch in January 2018, Rocket Lab’s Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered 171 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab’s Photon spacecraft platform has been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch pad in Virginia. To learn more, visit www.rocketlabusa.com.

+ Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our launch and space systems operation, launch schedule and window, safe and repeatable access to space, Neutron development, operational expansion and business strategy are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.rocketlabusa.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

+ Rocket Lab Investor Relations Contact

Colin Canfield

[email protected]

+ Rocket Lab Media Contact

Murielle Baker

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Satellite Technology Aerospace Transport Manufacturing Other Technology Other Transport



TEN Ltd. Celebrates 30 Years Since Inception

ATHENS, Greece, Oct. 12, 2023 (GLOBE NEWSWIRE) — TEN Ltd. (“TEN”) (NYSE: TNP) (the “Company”), celebrated its 30th year as a publicly listed company. TEN was listed on the Oslo Stock Exchange in 1993 and transferred its listing to the New York Stock Exchange in March 2002.

On October 10, 2023, Dr. Nikolaos P. Tsakos, Founder, CEO and his family hosted a memorable event in New York City along with members of the executive team. The event was attended by prominent financial journalist and anchor, Mrs. Nicole Petalides from Schwab Network, who delivered introductory remarks in the presence of Mr. Chris Taylor, Vice President and Global Head of Listings & Services at NYSE, Mr. Stefan Jekel, Head of International Listings at NYSE and other distinguished guests from the international shipping industry, banking and investment communities to mark this monumental occasion.

The Company proudly celebrated its journey which began 30 years ago with a fleet of four tankers to becoming one of the largest independent transporters of energy in the world owning a versatile fleet of 68 modern crude and product tankers, shuttle tankers and liquefied natural gas (“LNG”) vessels. TEN Ltd. is the energy transporter of choice for major oil companies and other blue chip global energy concerns.  

TEN’s focus on fleet modernity, operational excellence and balanced fleet employment has enabled the company to produce strong results throughout the market cycles. Over its 20-year presence on NYSE, TEN Ltd. has generated net income in excess of $2.5 billion and has made uninterrupted payments of common and preferred dividends in excess of $750 million, regardless of market cyclicality.

TEN Ltd. was among the first tanker companies to embrace the double hull vessel concept in the design and today remains committed to fleet modernization and green energy transition. TEN Ltd. has implemented a $6.0 billion newbuilding program on fleet expansion and renewal underpinning its prudent sustainable growth strategy aiming at reducing the Company’s environmental footprint.

On September 25, 2023, TEN Ltd. took delivery of an LNG powered Aframax tanker, Njord DF, the first in a series of four high-spec eco designed vessels built against long-term employment to a major European state-owned oil concern. The introduction of this vessel kickstarts the delivery of the Company’s existing green growth program with now nine remaining vessels which are expected to be gradually introduced to TEN’s fleet over the next ten quarters.

As of today, TEN Ltd. has secured over $2.5 billion in fleet revenue backlog.

Dr. Nikolaos P. Tsakos, Founder and CEO of the Company commented:

“This exceptional moment represents a significant milestone in our history as a publicly traded company that not only celebrates its achievements but more importantly, it propels us to look ahead into our next chapter and continue to push forward to better our business and our practices. We are grateful and appreciative to all our associates for their efforts so far and remain enthusiastic as we embark on the next phase of the Company’s development for the benefit of our shareholders.


TEN, founded in 1993 and celebrating this year 30 years as a public company, is one of the first and most established public shipping companies in the world. TEN’s diversified energy fleet currently consists of 68 double-hull vessels, including four dual-fuel LNG powered aframax vessels, two DP2 shuttle tankers, two scrubber-fitted suezmax vessels and two scrubber-fitted MR product tankers under construction, constituting a mix of crude tankers, product tankers and LNG carriers, totaling 8.4 million dwt.


Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those predicted by such forward-looking statements. TEN undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

For further information, please contact:


Tsakos Energy Navigation Ltd.
George Saroglou
+30210 94 07 710
[email protected]

Investor Relations / Media

Capital Link, Inc.
Nicolas Bornozis
Markella Kara
+212 661 7566
[email protected]

Photos accompanying this announcement are available at



COPT Defense Provides Conference Call Details to Discuss 3Q 2023 Results along with Investor Day Materials

COPT Defense Provides Conference Call Details to Discuss 3Q 2023 Results along with Investor Day Materials

COPT Defense Properties (NYSE: CDP) (“COPT Defense” or the “Company”) announces the release date and conference call details in which management will discuss third quarter 2023 results and announces the posting of its 2023 Investor Day materials.

3Q 2023 Results Details:

Results Release Date:                     Thursday, October 26, 2023 after the market closes

Conference Call Date:                     Friday, October 27, 2023

Time:                                                12:00 p.m. Eastern

Participants must register for the conference call at the link below to receive the dial-in number and personal pin. Registering only takes a few moments and provides direct access to the conference call without waiting for an operator. You may register at any time, including up to and after the call start time:


Participants can also listen to the conference call via a live webcast in the ‘News & Events – IR Calendar’ section of COPT Defense’s Investors website:


A replay of the conference call will be immediately available via webcast only on COPT Defense’s Investors website.

2023 Investor Day:

On October 11, 2023, the Company held an Investor Day and posted the accompanying materials in the ‘News & Events – IR Calendar’ section of COPT Defense’s Investors website:


About COPT Defense

COPT Defense is a REIT that owns, manages, leases, develops and selectively acquires office and data center properties. The majority of its portfolio is in locations that support the United States Government and its contractors, most of whom are engaged in national security, defense and information technology (“IT”) related activities servicing what the Company believes are growing, durable, priority missions (“Defense/IT Locations”). The Company also owns a portfolio of office properties located in select urban submarkets in the Greater Washington, DC/Baltimore region with durable Class-A office fundamentals and characteristics (“Regional Office Properties”). As of June 30, 2023, the Company derived 90% of its core portfolio annualized rental revenue from Defense/IT Locations and 10% from its Regional Office Properties. As of the same date and including 24 properties owned through unconsolidated joint ventures, the Company’s core portfolio of 192 properties encompassed 22.9 million square feet and was 95% leased. In September 2023, the Company changed its name from Corporate Office Properties Trust to COPT Defense Properties to better describe its investment strategy, and also changed the ticker symbol under which its common shares are publicly traded on the New York Stock Exchange from “OFC” to “CDP”.

Forward-Looking Information

This press release may contain “forward-looking” statements, as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that are based on the Company’s current expectations, estimates and projections about future events and financial trends affecting the Company. Forward-looking statements can be identified by the use of words such as “may,” “will,” “should,” “could,” “believe,” “anticipate,” “expect,” “estimate,” “plan” or other comparable terminology. Forward-looking statements are inherently subject to risks and uncertainties, many of which the Company cannot predict with accuracy and some of which the Company might not even anticipate. Although the Company believes that the expectations, estimates and projections reflected in such forward-looking statements are based on reasonable assumptions at the time made, the Company can give no assurance that these expectations, estimates and projections will be achieved. Future events and actual results may differ materially from those discussed in the forward-looking statements and the Company undertakes no obligation to update or supplement any forward-looking statements.

The areas of risk that may affect these expectations, estimates and projections include, but are not limited to, those risks described in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

Source: COPT Defense Properties

IR Contacts:

Venkat Kommineni, CFA


[email protected]

Michelle Layne


[email protected]

KEYWORDS: District of Columbia Maryland United States North America

INDUSTRY KEYWORDS: Other Construction & Property Commercial Building & Real Estate Construction & Property REIT



Western Alliance Bancorporation Announces Third Quarter 2023 Earnings Release Date, Conference Call and Webcast

Western Alliance Bancorporation Announces Third Quarter 2023 Earnings Release Date, Conference Call and Webcast

Western Alliance Bancorporation (NYSE: WAL) announced today that it plans to release its third quarter 2023 financial results after the market closes on Thursday, October 19, 2023. Ken Vecchione, President and CEO and Dale Gibbons, Vice Chairman and CFO will host a conference call at 12:00 p.m. ET on Friday, October 20, 2023 to discuss the Company’s performance.

Participants may access the call by dialing 1-833-470-1428 using the access code 282175 or via live audio webcast using the website link: https://events.q4inc.com/attendee/123936476.

The webcast is also available through the Company’s website at www.westernalliancebancorporation.com. Participants should log in at least 15 minutes early to receive instructions. The call will be recorded and made available for replay October 20th after 3:00 p.m. ET until November 20th at 11:00 p.m. ET by dialing 1-866-813-9403 using the access code: 831794.

About Western Alliance Bancorporation

With more than $65 billion in assets, Western Alliance Bancorporation (NYSE:WAL) is one of the country’s top-performing banking companies. Through its primary subsidiary, Western Alliance Bank, Member FDIC, business clients benefit from a full spectrum of tailored banking solutions and outstanding service delivered by industry experts who put customers first. Influential sources from Forbes to American Banker again rank Western Alliance Bank among the top U.S. banks in 2023. Serving clients across the country wherever business happens, Western Alliance Bank operates individual, full-service banking and financial brands with offices in key markets nationwide. For more information, visit Western Alliance Bancorporation.


Miles Pondelik, 602-346-7462

Email: [email protected]


Stephanie Whitlow, 480-998-6547

Email: [email protected]

KEYWORDS: United States North America Arizona

INDUSTRY KEYWORDS: Banking Professional Services Finance



Comerica and FHLB Dallas Celebrate Opening of Affordable Apartments Helped by $750K in Funding

Comerica and FHLB Dallas Celebrate Opening of Affordable Apartments Helped by $750K in Funding

Houston Mayor and Housing Advocates Celebrate Opening of New Hope Housing Savoy

Local politicians, including Houston Mayor Sylvester Turner, turned out to celebrate today’s grand opening of New Hope Housing (NHH) Savoy, a multimillion-dollar, 120-unit supportive housing project. It was built with the assistance of a $750,000 Affordable Housing Program (AHP) subsidy provided by the Federal Home Loan Bank of Dallas (FHLB Dallas) through one of its members, Comerica Bank.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231012053754/en/

New Hope Housing Savoy, an affordable housing development in Houston, Texas, received a $750,000 subsidy from the Federal Home Loan Bank of Dallas via its member Comerica Bank and celebrated its grand opening today. (Photo: Business Wire)

New Hope Housing Savoy, an affordable housing development in Houston, Texas, received a $750,000 subsidy from the Federal Home Loan Bank of Dallas via its member Comerica Bank and celebrated its grand opening today. (Photo: Business Wire)

NHH Savoy will provide families and individuals with low to modest incomes with affordable housing options in the Gulfton-Sharpstown neighborhood of Houston, Texas.

“The city takes great pride in collaborating with organizations like New Hope Housing to create beautiful communities that benefit Houstonians. New Hope Housing Savoy is not just a place to live; it is a community that fosters growth, support and stability,” said Houston Mayor Sylvester Turner. “We are grateful for the generous support of financial partners like FHLB Dallas whose funding via Comerica Bank made this project possible. Together, we can celebrate the creation of a truly remarkable facility that will provide housing for individuals and families in need.”

FHLB Dallas awards AHP subsidies through its member financial institutions to benefit very low-to moderate-income households across its five-state District.

“We thank Comerica Bank and FHLB Dallas for funding affordable solutions to the housing shortage in Houston,” said Joy Horak-Brown, president and CEO of New Hope Housing. “Housing and setting up families with crucial support services provides the stability needed to overcome economic disparities.”

Comerica’s Houston Market President Jason Baker said Comerica Bank is committed to helping communities prosper by providing funding for affordable real estate development.

“Thanks to the support of FHLB Dallas, we’ve provided gap funding to several affordable housing projects in Houston including NHH Savoy,” Mr. Baker said. “We are delighted to have partnered with FHLB Dallas to help bring this landmark project to fruition.”

AHP funds are intended to assist FHLB Dallas members in financing the purchase, construction and/or rehabilitation of owner-occupied, rental or transitional housing and housing for homeless individuals. The funds must be used to benefit households with incomes at or below 80 percent of the median income for the area.

In 2022, FHLB Dallas awarded nearly $17.2 million in AHP subsidies to 26 projects, primarily within its five-state District of Arkansas, Louisiana, Mississippi, New Mexico and Texas. FHLB Dallas will announce 2023 AHP awards later this year.

“Given our long relationship and shared commitment to affordable housing, we are happy to provide funding through Comerica Bank via the AHP to support NHH’s mission of preserving housing affordability in Southwest Houston,” said Greg Hettrick, senior vice president and director of Community Investment at FHLB Dallas.

For more information about the AHP, visit fhlb.com/ahp.

About Comerica

Comerica Incorporated (NYSE: CMA) is a financial services company headquartered in Dallas, Texas, and strategically aligned by three business segments: The Commercial Bank, The Retail Bank and Wealth Management. Comerica, one of the 25 largest U.S. financial holding companies, focuses on building relationships and helping people and businesses be successful. Comerica provides more than 400 banking centers across the country with locations in Arizona, California, Florida, Michigan and Texas. Founded 174 years ago in Detroit, Michigan, Comerica continues to expand into new regions, including its Southeast Market, based in North Carolina, and Mountain West Market in Colorado. Comerica has offices in 17 states and services 14 of the 15 largest U.S. metropolitan areas, as well as Canada and Mexico. Comerica reported total assets of $90.8 billion at June 30, 2023. Learn more about how Comerica is raising expectations of what a bank can be by visiting www.comerica.com, and follow us on Facebook, Twitter, Instagram and LinkedIn.

About the Federal Home Loan Bank of Dallas

The Federal Home Loan Bank of Dallas is one of 11 district banks in the FHLBank System created by Congress in 1932. FHLB Dallas, with total assets of $174 billion as of June 30, 2023, is a member-owned cooperative that supports housing and community development by providing competitively priced loans and other credit products to approximately 800 members and associated institutions in Arkansas, Louisiana, Mississippi, New Mexico and Texas. For more information, visit our website at fhlb.com.

Corporate Communications

Federal Home Loan Bank of Dallas

fhlb.com, (214) 441-8445

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Construction & Property Finance Urban Planning Banking Professional Services Building Systems Environmental, Social and Governance (ESG) Other Construction & Property Residential Building & Real Estate


New Hope Housing Savoy, an affordable housing development in Houston, Texas, received a $750,000 subsidy from the Federal Home Loan Bank of Dallas via its member Comerica Bank and celebrated its grand opening today. (Photo: Business Wire)
Houston Mayor Sylvester Turner celebrates the grand opening of New Hope Housing Savoy, an affordable housing development that received a $750,000 subsidy from the Federal Home Loan Bank of Dallas via its member Comerica Bank. (Photo: Business Wire)

PCT Shareholders with Significant Losses Should Contact Robbins Regarding Their Rights and Remedies in Connection with the PureCycle Technologies, Inc. Class Action

SAN DIEGO, Oct. 12, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired PureCycle Technologies, Inc. (NASDAQ: PCT) securities between August 8, 2023 and September 13, 2023. PureCycle claims it is commercializing a patented purification recycling technology, originally developed by The Procter & Gamble Company (“P&G”), for restoring waste polypropylene into resin with near-virgin characteristics, called ultra-pure recycled resin.

For more information, submit a form, email Aaron Dumas, Jr., or give us a call at (800) 350-6003.

What is this Case About: PureCycle Technologies, Inc. (PCT) Failed to Inform Investors its Ironton Facility Experienced a Power Outage

According to the complaint, in early 2023, PureCycle claimed that it was finalizing construction and commissioning at its first commercial scale recycling facility (the “Ironton Facility”). On September 13, 2023, PureCycle disclosed that its Ironton Facility experienced a full plant power outage on August 7, 2023, which required the facility to halt operations. The Company further disclosed that it replaced a seal that purportedly failed as a result of the power outage, and initiated facility restart procedures on September 11, 2023. On this news, PureCycle’s stock price fell $1.395, or 18.4%, to close at $6.18 per share on September 14, 2023, on unusually heavy trading volume.

What Now: Similarly situated shareholders may be eligible to participate in the class action against PureCycle Technologies, Inc. Shareholders who want to act as lead plaintiff for the class must file their motion for lead plaintiff by November 28, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against PureCycle Technologies, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
[email protected]
(800) 350-6003



FCPT Announces Acquisition of an Oak Street Health Property for $2.4 Million

FCPT Announces Acquisition of an Oak Street Health Property for $2.4 Million

Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of an Oak Street Health property for $2.4 million. The property is located in a highly trafficked corridor in Arkansas and is corporate-operated under a long-term, net lease. The transaction was priced at a cap rate in range with previous FCPT transactions.

About FCPT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the ownership, acquisition and leasing of restaurant and retail properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries. Additional information about FCPT can be found on the website at www.fcpt.com.

Four Corners Property Trust:

Bill Lenehan, 415-965-8031


Gerry Morgan, 415-965-8032


KEYWORDS: California Arkansas United States North America

INDUSTRY KEYWORDS: REIT Restaurant/Bar Retail Commercial Building & Real Estate Construction & Property